JGC
ORKA

J. Goldman & Co’s Oruka Therapeutics ORKA Stock Holding History

J. Goldman & Co’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+12,356
New +$823K 0.03% 424

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

J. Goldman & Co's ORKA Position: Q2 2026 in Review

J. Goldman & Co opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 12,356 shares worth $1.18M. The stake represents 0.03% of the portfolio and ranks #424 among its holdings.

255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • J. Goldman & Co held 12,356 shares of Oruka Therapeutics worth $1.18M as of Q2 2026.
  • Oruka Therapeutics was a new J. Goldman & Co position in Q2 2026.
  • Oruka Therapeutics made up 0.03% of J. Goldman & Co's portfolio in Q2 2026, its #424 holding.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.